Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Miriam Hurst"'
Autor:
Peter Storey, Richard Steele, Rohan Ameratunga, Russell Barker, Alana Cavadino, Thomas Hills, Andrew Baker, Charlotte Slade, Miriam Hurst, Ben McGettigan, Caroline Allan, Ignatius Chua, Shanthi Ameratunga, Wikke Koopmans, Leon Huang, Maia Brewerton, Nicholas Kennedy, See-Tarn Woon, Anthony Jordan, Yeri Ahn
Publikováno v:
Clin Exp Immunol
SummaryCommon variable immunodeficiency disorders (CVID) are multi-system disorders where target organ damage is mediated by infective, autoimmune and inflammatory processes. Bronchiectasis is probably the most common disabling complication of CVID.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ece36f218daf971c248234e8968c5bfb
https://doi.org/10.1111/cei.13595
https://doi.org/10.1111/cei.13595
Publikováno v:
Internal medicine journalReferences. 52(10)
Previous anaphylaxis or immediate allergic reaction to polyethylene glycol (PEG; also known as macrogol) is considered a contraindication to the BNT162b2 mRNA COVID-19 vaccine, which contains 50 ug of PEG at a molecular weight of 2000, and this compo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13ecbd21a38fe7b08a4e2bad81f1b597
https://pubmed.ncbi.nlm.nih.gov/36000384
https://pubmed.ncbi.nlm.nih.gov/36000384
Autor:
Rafi Raja, Peter T. Chapman, John L. O'Donnell, Miriam Hurst, Chris Frampton, Jan Ipenburg, Lisa K. Stamp
Publikováno v:
The Journal of Rheumatology. 39:2098-2103
Objective.To compare the performance of the 2010 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria with the 1987 American Rheumatism Association (ARA) criteria for rheumatoid arthritis (RA) in an early arthritis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae0d0d1187a2b0dc5345516bbdf38e2
https://doi.org/10.3899/jrheum.120226
https://doi.org/10.3899/jrheum.120226
Publikováno v:
Drugs. 62:169-207
Gatifloxacin is an 8-methoxy fluoroquinolone antibacterial agent. The drug has a broader spectrum of antibacterial activity than the older fluoroquinolones (e.g. ciprofloxacin) and shows good activity against many Gram-positive and Gram-negative path
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13d32f82966d9fbdb3640d06aff73639
https://doi.org/10.2165/00003495-200262010-00007
https://doi.org/10.2165/00003495-200262010-00007
Autor:
Greg L. Plosker, Miriam Hurst
Publikováno v:
Disease Management and Health Outcomes. 10:133-136
A number of first-line chemotherapy options for patients with advanced non-small cell lung cancer (NSCLC) are advocated in treatment guidelines and/or by various clinical investigators. Platinum-based chemotherapy has clearly demonstrated efficacy in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c657f3585f7a31fbad626b7943e548bf
https://doi.org/10.2165/00115677-200210020-00009
https://doi.org/10.2165/00115677-200210020-00009
Publikováno v:
Drugs. 62:2127-2167
UNLABELLED Levofloxacin is the L-form of the fluoroquinolone antibacterial agent, ofloxacin. In in vitro studies, levofloxacin demonstrated a broad range of activity against Gram-positive and -negative organisms and anaerobes. The drug is more active
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6145ac41cc9c6bd97fda3b0450b67f0
https://doi.org/10.2165/00003495-200262140-00013
https://doi.org/10.2165/00003495-200262140-00013
Autor:
Miriam Hurst, Lisa K. Stamp
Publikováno v:
The Journal of Rheumatology. 37:686-688
Pneumocystis jiroveci pneumonia (PCP) is the most common opportunistic infection in patients with human immunodeficiency virus (HIV)1. PCP can also affect patients with autoimmune diseases [e.g., systemic lupus erythematosus (SLE), Wegener’s granul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4161536d55257064883a2bf56fa37929
https://doi.org/10.3899/jrheum.091426
https://doi.org/10.3899/jrheum.091426
Autor:
Diana Faulds, Miriam Hurst
Publikováno v:
Drugs. 60:1371-1379
Lopinavir is a protease inhibitor with high specificity for HIV-1 protease. Ritonavir strongly inhibits lopinavir metabolism; coadministration of lopinavir and ritonavir in healthy volunteers increased the area under the lopinavir plasma concentratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::794e8afd8263073b7cc16c4177ff34b7
https://doi.org/10.2165/00003495-200060060-00009
https://doi.org/10.2165/00003495-200060060-00009
Autor:
Harriet M. Lamb, Miriam Hurst
Publikováno v:
CNS Drugs. 14:51-80
Fluoxetine is a selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitor (SSRI). Although its mechanism of action in anxiety disorders is unclear, it is thought to act by enhancing serotonergic neurotransmission and down-regulating central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98ae2327268f273993d92f18c3256488
https://doi.org/10.2165/00023210-200014010-00005
https://doi.org/10.2165/00023210-200014010-00005
Autor:
Miriam Hurst, Caroline M. Spencer
Publikováno v:
Drugs. 59:981-1006
UNLABELLED Ebastine is a second-generation antihistamine which undergoes transformation to its active metabolite, carebastine. Its antihistaminic and antiallergic effects have been demonstrated in in vitro and in vivo studies, in addition to data obt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9b7750e273f8727eab5d745f54a815f
https://doi.org/10.2165/00003495-200059040-00018
https://doi.org/10.2165/00003495-200059040-00018